Abstract
Little is known about the factors that affect treatment outcome in very young children with acute myeloid leukemia (AML). We therefore analyzed the prognostic impact of various presenting clinical and laboratory features by discrete age group in 299 children with AML treated in four consecutive clinical trials between 1980 and 1997. Differences in presenting features, as well as treatment outcome, were compared between children aged 12 months or less (n = 28) or 13 to 24 months (n = 28) and those more than 24 months of age (n = 243). Children in the two youngest groups (24 months of age or less) had similar presenting features and treatment outcome. Collectively, these 56 children were significantly more likely than the 243 older patients to have M4 or M5 leukemia (70% vs 30%), CNS leukemia (33% vs 22%), the t(9;11) (p22;q23) (18% vs6%) or other 11q23 translocations (23% vs 3%), and less likely to have Auer rods (2% vs 54%) or the t(8;21) (q22;q22) (0% vs 17%). Among patients aged 24 months or less, two factors independently predicted a favorable prognosis: FAB M4 or M5 leukemia (relative risk of relapse, 0.4; 95% confidence interval, 0.2–0.9) and the t(9;11) (relative risk, 0.3; 95% confidence interval, 0.1–1.0). Leukocyte count and 11q23 translocations other than the t(9;11) lacked prognostic significance. Among older patients, a leukocyte count <50 × 109/l and the presence of the t(9;11) conferred a favorable prognosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pui C-H, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land VJ, Pullen DJ, Steuber CP, Behm FG, Borowitz MJ . Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11) (q21;q23): a collaborative study of 40 cases Blood 1991 77: 440–447
Chen C-S, Sorensen PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH . Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome Blood 1993 81: 2386–2393
Basso G, Giuseppe B, Rondelli R, Covezzoli A, Putti MC . The role of immunophenotype in acute lymphoblastic leukemia of infant age Leuk Lymphoma 1994 15: 51–60
Chessells JM, Eden OB, Bailey CC, Lilleyman JS, Richards SM . Acute lymphoblastic leukaemia in infancy: experience MRC UKALL Trials. Report from the Medical Research Council Working Party on Childhood Leukaemia Leukemia 1994 8: 1275–1279
Pui C-H, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, Head DR, Mahmoud HH, Sandlund JT, Furman WL, Roberts WM, Crist WM, Raimondi SC . 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia J Clin Oncol 1994 12: 909–915
Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML . Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblasitc leukemia: A Pediatric Oncology Group Study Blood 1994 84: 570–573
Cimino G, Rapanotti MC, Rivolta A, Lo Coco F, D'Arcangelo E, Rondelli R, Basso G, Barisone E, Rosanda C, Santostasi T, Canaani E, Masera G, Mandelli F, Biondi A . Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias Leukemia 1995 9: 391–395
Pui C-H, Kane JR, Crist WM . Biology and treatment of infant leukemias Leukemia 1995 9: 762–769
Pui C-H, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG, Sandlund JT, Rivera GK, Evans WE, Crist WM, Krance R . Prognostic factors in the acute lymphoid and myeloid leukemias of infants Leukemia 1995 10: 952–956
Silverman LB, McLean TW, Gelber RD, Donnelly MJ, Gilliland DG, Tarbell NJ, Sallan SE . Intensified therapy for infants with acute lymphoblastic leukemia. Results from the Dana-Farber Cancer Institute Consortium Cancer 1997 80: 2285–2295
Taki T, Ida K, Bessho F, Hanada R, Kikuchi K, Yamamoto K, Sako M, Tsuchida M, Seto M, Ueda R, Hayashi Y . Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia Leukemia 1996 10: 1303–1307
Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien RT, Steinherz PG, Zeltzer PM, Gaynon, PS, Trigg ME, Uckun FM . Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group J Clin Oncol 1999 17: 445–455
Dördelmann M, Reiter A, Borkhardt A, Ludwig W-D, Götz N, Viehmann S, Gadner H, Riehm J, Schrappe M . Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia Blood 1999 94: 1209–1217
Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, Steinherz PG, Zeltzer P, Hammond D, Reaman GH . Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Children's Cancer Group Blood 1994 83: 2274–2284
Heerema NA, Sather HN, Ge J, Arthur DC, Hilden JM, Trigg ME, Reaman GH . Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) – a report of the Children's Cancer Group Leukemia 1999 13: 679–686
Rubnitz JE, Camitta BM, Mahmoud H, Raimondi SC, Carroll AJ, Borowitz MJ, Shuster JJ, Link MP, Pullen DJ, Downing JR, Behm FG, Pui, C-H . Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19) (q23;p13.3) translocation J Clin Oncol 1999 17: 191–196
Amadori S, Ceci A, Comelli Adriana C, Comelli A, Madon E, Masera G, Nespoli L, Paolucci G, Zanesco L, Covelli A, Mandelli F . Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204 J Clin Oncol 1987 5: 1356–1363
Grier HE, Gelber RD, Camitta BM, Delorey MJ, Link MP, Price KN, Leavitt PR, Weinstein HJ . Prognostic factors in childhood acute myelogenous leukemia J Clin Oncol 1987 5: 1026–1032
Ravindranath Y, Steuber CP, Krischer J, Civin CI, Ducore J, Vega R, Pitel P, Inoue S, Bleher E, Sexauer C, Hutter J, Vietti T . High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study J Clin Oncol 1991 9: 572–580
Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll A, Inoue S, Camitta B, Weinstein HJ . Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood New Engl J Med 1996 334: 1428–1434
Woods WG, Kobrinsky N, Buckley JD, Lee JW, Sanders J, Neudorf S, Gold S, Barnard DR, DeSwarte J, Dusenbery K, Kalousek D, Arthur DC, Lange BJ . Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group Blood 1996 87: 4979–4989
Creutzig U, Zimmermann M, Ritter J, Henze G, Graf N, Löffler H, Schellong G . Definition of a standard-risk group in children with AML Br J Haematol 1999 104: 630–639
Pui C-H, Kalwinsky DK, Schell MJ, Mason CA, Mirro J Jr, Dahl GV . Acute nonlymphoblastic leukemia in infants: clinical presentation and outcome J Clin Oncol 1988 6: 1008–1013
Buckley JD, Chard RL, Baehner RL, Nesbit ME, Lampkin BC, Woods WG, Hammond GD . Improvement in outcome for children with acute nonlymphocytic leukemia. A report from the Childrens Cancer Study Group Cancer 1989 63: 1457–1465
Lie SO, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G . A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome Br J Haematol 1996 94: 82–88
Stevens RF, Hann IM, Wheatley K, Gray RG . Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical research Council's 10th AML trial Br J Haematol 1998 101: 130–140
Sorensen PHB, Chen C-S, Smith FO, Arthur DC, Domer PH, Bernstein ID, Korsmeyer SJ, Hammond GD, Kersey JH . Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes J Clin Invest 1994 93: 429–437
Hilden JM, Smith FO, Frestedt JL, McGlennen R, Howells WB, Sorensen PHB, Arthur DC, Woods WG, Buckley J, Bernstein ID, Kersey JH . MLL gene rearangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia Blood 1997 89: 3801–3805
Satake N, Maseki N, Nishiyama M, Kobayashi H, Sakurai M, Inaba H, Katano N, Horikoshi Y, Eguchi H, Miyake M, Seto M, Kaneko Y . Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants Leukemia 1999 13: 1013–1017
Dahl GV, Kalwinsky DK, Mirro J Jr, Look AT, Pui C-H, Murphy SB, Mason C, Ruggiero M, Schell M, Johnson FL, Thomas ED . Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission J Clin Oncol 1990 8: 295–303
Kalwinsky D, Mirro J Jr, Schell M, Behm F, Mason C, Dahl GV . Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide J Clin Oncol 1988 6: 1134–1143
Hurwitz CA, Krance R, Schell MJ, Santana VM, Brenner MK, Ribeiro R, Roberts WM, Mahmoud H, Belt J, Crom W, Shearer PD, Mirro J Jr . Current strategies for treatment of acute myeloid leukemia at St. Jude Children's Research Hospital Leukemia 1992 6: (Suppl. 2) 39–43
ISCN 1995 . Mitelman F (ed). An International System for Human Cytogenetic Nomenclature Karger: Basel 1995
Odom LF, Gordon EM . Acute monoblastic leukemia in infancy and early childhood: successful treatment with an epipodophyllotoxin Blood 1984 64: 875–882
Nishikawa A, Nakamura Y, Nobori U, Aoki T, Higashino H, Matsui T, Kobayashi Y, Yamashita M, Unishi G . Acute monocyticleukemia in children. Response to VP-16–213 as a single agent Cancer 1987 60: 2146–2149
Shuster JJ, Wacker SP, Pullen J, Humbert J, Land VJ Jr, Mahoney DH, Lauer S, Look AT, Borowitz MJ, Carroll AJ, Camitta B . Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study J Clin Oncol 1998 16: 2854–2863
Pui C-H, Boyett JM, Relling MV, Harrison PL, Rivera GK, Behm FG, Sandlund JT, Ribeiro RC, Rubnitz JE, Gajjar A, Evans WE . Sex differences in prognosis for children with acute lymphoblastic leukemia J Clin Oncol 1999 17: 818–824
Kalwinsky DK, Raimondi SC, Schell MJ, Mirro J Jr, Santana VM, Behm F, Dahl GV, Williams D . Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia J Clin Oncol 1990 8: 78–83
Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R, Murphy SB, Vardiman JW, Larson RA, Le Beau MM, Rowley JD . Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo Leukemia 1995 9: 95–101
Mrózek K, Heinonen K, Lawrence D, Carroll AJ, Koduru PRK, Rao KW, Strout MP, Hutchison RE, Moore JO, Mayer RJ, Schiffer CA, Bloomfield CD . Adult patients with de novo acute myeloid leukemia and t(9;11) (p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B Study Blood 1997 90: 4532–4538
Pui C-H, Evans WE . Acute lymphoblastic leukemia New Engl J Med 1998 339: 605–615
Acknowledgements
We thank Annette C Stone for data management and Doris Hurdle for typing the manuscript. This work was supported by grant Nos CA21765 and CA20180 from the National Cancer Institute, by a Center of Excellence grant from the State of Tennessee, and by the American Lebanese Syrian Associated Charities (ALSAC).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pui, CH., Raimondi, S., Srivastava, D. et al. Prognostic factors in infants with acute myeloid leukemia. Leukemia 14, 684–687 (2000). https://doi.org/10.1038/sj.leu.2401725
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401725
Keywords
This article is cited by
-
Whole exome sequencing of pediatric leukemia reveals a novel InDel within FLT-3 gene in AML patient from Mizo tribal population, Northeast India
BMC Genomic Data (2022)
-
Long noncoding RNAs as regulators of pediatric acute myeloid leukemia
Molecular and Cellular Pediatrics (2022)
-
Acute Leukemia in Infants
Current Oncology Reports (2021)
-
Improved outcome of childhood acute myeloid leukemia in an Eastern European country: Lithuanian experience
European Journal of Pediatrics (2017)
-
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid
Annals of Hematology (2017)